Why Disease Elimination Demands More Than Control 05/09/2026 Health Policy Watch “When you aim to deliver zero, and that is the goal of eradication, what it means is every person, every community, every village is equally important.” That is how Dr. Jamal Ahmed, WHO Director for Polio Eradication, explains why eliminating a disease requires a fundamentally different level of ambition than simply controlling it. Speaking on […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 07/11/2025 Elaine Ruth Fletcher The United States, backed by Argentina, was reportedly blocking the G20 consensus on the final G20 Health Ministers’ statement – following their fourth and final working group meeting of the year Friday in Limpopo, South Africa, Health Policy Watch has learned. In a visible snub to the rest of the group, the US delegation also […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 07/11/2025 Elaine Ruth Fletcher The United States, backed by Argentina, was reportedly blocking the G20 consensus on the final G20 Health Ministers’ statement – following their fourth and final working group meeting of the year Friday in Limpopo, South Africa, Health Policy Watch has learned. In a visible snub to the rest of the group, the US delegation also […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 07/11/2025 Elaine Ruth Fletcher The United States, backed by Argentina, was reportedly blocking the G20 consensus on the final G20 Health Ministers’ statement – following their fourth and final working group meeting of the year Friday in Limpopo, South Africa, Health Policy Watch has learned. In a visible snub to the rest of the group, the US delegation also […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 07/11/2025 Elaine Ruth Fletcher The United States, backed by Argentina, was reportedly blocking the G20 consensus on the final G20 Health Ministers’ statement – following their fourth and final working group meeting of the year Friday in Limpopo, South Africa, Health Policy Watch has learned. In a visible snub to the rest of the group, the US delegation also […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Why Ending Malaria Depends on Bold Financing and Global Leadership 03/10/2025 Duma Gideon Boko The President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), writes about the urgency of mobilising funding to defend the gains and further progress in the fight against malaria. Despite decades of progress, we are not on track to defeat malaria in Africa. Without more resolve, innovation, financing, and […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> ‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
‘Critical Lack’ of Antifungal Treatments and Growing Drug Resistance 01/04/2025 Kerry Cullinan There is a “critical lack” of medicines and diagnostic tools for invasive fungal diseases, according to the World Health Organization (WHO), which released its first analysis of antifungals on Tuesday. Invasive fungal diseases are on the rise, particularly in immune-compromised people – yet they get little attention or resources, asserts the global body. Common infections […] Continue reading -> PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
PEPFAR Reauthorisation Expires With No Clarity About Renewed US Funding for HIV 25/03/2025 Kerry Cullinan The US Congress’s one-year reauthorisation of the President’s Emergency Plan for AIDS Relief (PEPFAR) expires on Tuesday (25 March) and there is no clarity about its future – other than that it is likely to be slashed. The only Bill up for discussion on this date that has any connection to PEPFAR is the Reorganizing […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts
Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> Posts navigation Older posts